This bioscience company has had promising financials, yet one of its top executives exited his entire direct equity ownership ...

Twist Bioscience (TWST) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports ...

The Phase I/II study will enrol approximately 368 adults aged 18 years and above.

The Nasdaq-listed company has recurring losses and no revenue.

Paine Schwartz Partners–backed HGS BioScience, Jacksonville, Flordia, a leading provider of biological crop solutions, ...

BOULDER — Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round. Think Bioscience Inc. recently raised an oversubscribed $55 million Series A round.

Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA ...

A new Bend-based bioscience lab could become operational as early as December of this year, with manufacturing and analytical capabilities coming online in mid-2023. Earlier this month, the ...

After striking out in the pandemic phase of COVID-19 with its belated vaccine, Novavax seeks to recover in the endemic phase. And a big part of the company's plan centers around enhancing its ...

Nimacimab alone demonstrated 23.5% weight loss, comparable to monlunabant and tirzepatide alone. “This new preclinical study highlights that a truly peripherally-restricted CB1 ...

Margaret R. McLean delivered this address to the Keck Graduate Institute Convocation in September 2010. She is associate director of the Markkula Center for Applied Ethics and Director of Bioethics.